Peptides
The Next Generation of GLP-1s: PYY Analogs, AI-Designed Molecules, and Weekly Insulin
Semaglutide and tirzepatide rewrote the metabolic playbook. The pipeline behind them is already bifurcating — and what arrives next will look less like one blockbuster shot and more like a stack.